Raphael Moriez
Raphael Moriez has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
Jean Fioramonti
MR 1054, INRA, Neuro-Gastroenterology and Nutrition Unit, ESA-Purpan, Toulouse, France
4 shared publicationsLionel Bueno
MR 1054, INRA, Neuro-Gastroenterology and Nutrition Unit, ESA-Purpan, Toulouse, France
4 shared publicationsVassilia Theodorou
4 shared publicationsCharlotte Baudry
INSERM, U913, Institut Fédératif de Recherche Thérapeutique, 8 quai Moncousu, BP 70721, 44007 Nantes Cedex 01, France
3 shared publicationsHelene Eutamene
3 shared publications- Mathilde Leveque
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, Toxalim, UMR1331, INRAE/INP/UPS, Toulouse, France; Neurogastroenterology and Nutrition, Toxalim, Toulouse
3 shared publications
Latest Publications
- Open Access
- 16 September 2013
- Published by Wiley in The Journal of Physiology
- Vol. 591 (20) , 5125-5139
Properties of myenteric neurones and mucosal functions in the distal colon of diet‐induced obese mice
Key points: We investigated altered colonic functions in high fat diet‐induced obesity in pre‐diabetic mice. After feeding an adipogenic diet for 12 weeks, accelerated colonic transit was associated with upregulation and enhanced signalling of acetylcholine and serotonin, two key mediators in the enteric nervous system (ENS). Importantly, these changes occurred without signs of impaired mucosal integrity or immune cell infiltration in the gut wall. Neuronal sensitization was not observed in obese mice fed for 4 weeks. Weight gain correlated positively with the level of adipocyte markers and the degree of neuronal sensitization. We conclude that enhanced neural excitation in the colon by acetylcholine and serotonin is a key feature of a later phase of obesity and is involved in altered ENS functions and abnormal colonic transit. Furthermore, the results suggest that the occurrence of altered gut functions in obesity is independent of inflammation in the gut wall. Abstract Colonic transit and mucosal integrity are believed to be impaired in obesity. However, a comprehensive assessment of altered colonic functions, inflammatory changes and neuronal signalling of obese animals is missing. In mice, we studied the impact of diet‐induced obesity (DIO) on: (i) in vivo colonic transit; (ii) signalling in the myenteric plexus by recording responses to nicotine and 2‐methyl‐5‐hydroxytryptamine (2‐methyl‐5‐HT), together with the expression of tryptophan hydroxylase (TPH) 1 and 2, serotonin reuptake transporter, choline acetyltransferase and the paired box gene 4; and (iii) expression of proinflammatory cytokines, epithelial permeability and density of macrophages, mast cells and enterochromaffin cells. Compared with controls, colon transit and neuronal sensitivity to nicotine and 2‐methyl‐5‐HT were enhanced in DIO mice fed for 12 weeks. This was associated with increased tissue acetylcholine and 5‐hydroxytryptamine (5‐HT) content, and increased expression of TPH1 and TPH2. In DIO mice, upregulation of proinflammatory cytokines was found in fat tissue, but not in the gut wall. Accordingly, mucosal permeability or integrity was unaltered without signs of immune cell infiltration in the gut wall. Body weight showed positive correlations with adipocyte markers, tissue levels of 5‐HT and acetylcholine, and the degree of neuronal sensitization. DIO mice fed for 4 weeks showed no neuronal sensitization, had no signs of gut wall inflammation and showed a smaller increase in leptin, interleukin‐6 and monocyte chemoattractant protein 1 expression in fat tissue. DIO is associated with faster colonic transit and impacts on acetylcholine and 5‐HT metabolism with enhanced responsiveness of enteric neurones to both mediators after 12 weeks of feeding. Our study demonstrates neuronal plasticity in DIO prior to the development of a pathological histology or abnormal mucosal functions. This questions the common assumption that increased mucosal inflammation and permeability initiate functional disorders in obesity.
- 16 September 2013
- Published by Wiley in The Journal of Physiology
- Vol. 591 (20) , 5125-5139
Open AccessProperties of myenteric neurones and mucosal functions in the distal colon of diet‐induced obese mice
Key points: We investigated altered colonic functions in high fat diet‐induced obesity in pre‐diabetic mice. After feeding an adipogenic diet for 12 weeks, accelerated colonic transit was associated with upregulation and enhanced signalling of acetylcholine and serotonin, two key mediators in the enteric nervous system (ENS). Importantly, these changes occurred without signs of impaired mucosal integrity or immune cell infiltration in the gut wall. Neuronal sensitization was not observed in obese mice fed for 4 weeks. Weight gain correlated positively with the level of adipocyte markers and the degree of neuronal sensitization. We conclude that enhanced neural excitation in the colon by acetylcholine and serotonin is a key feature of a later phase of obesity and is involved in altered ENS functions and abnormal colonic transit. Furthermore, the results suggest that the occurrence of altered gut functions in obesity is independent of inflammation in the gut wall. Abstract Colonic transit and mucosal integrity are believed to be impaired in obesity. However, a comprehensive assessment of altered colonic functions, inflammatory changes and neuronal signalling of obese animals is missing. In mice, we studied the impact of diet‐induced obesity (DIO) on: (i) in vivo colonic transit; (ii) signalling in the myenteric plexus by recording responses to nicotine and 2‐methyl‐5‐hydroxytryptamine (2‐methyl‐5‐HT), together with the expression of tryptophan hydroxylase (TPH) 1 and 2, serotonin reuptake transporter, choline acetyltransferase and the paired box gene 4; and (iii) expression of proinflammatory cytokines, epithelial permeability and density of macrophages, mast cells and enterochromaffin cells. Compared with controls, colon transit and neuronal sensitivity to nicotine and 2‐methyl‐5‐HT were enhanced in DIO mice fed for 12 weeks. This was associated with increased tissue acetylcholine and 5‐hydroxytryptamine (5‐HT) content, and increased expression of TPH1 and TPH2. In DIO mice, upregulation of proinflammatory cytokines was found in fat tissue, but not in the gut wall. Accordingly, mucosal permeability or integrity was unaltered without signs of immune cell infiltration in the gut wall. Body weight showed positive correlations with adipocyte markers, tissue levels of 5‐HT and acetylcholine, and the degree of neuronal sensitization. DIO mice fed for 4 weeks showed no neuronal sensitization, had no signs of gut wall inflammation and showed a smaller increase in leptin, interleukin‐6 and monocyte chemoattractant protein 1 expression in fat tissue. DIO is associated with faster colonic transit and impacts on acetylcholine and 5‐HT metabolism with enhanced responsiveness of enteric neurones to both mediators after 12 weeks of feeding. Our study demonstrates neuronal plasticity in DIO prior to the development of a pathological histology or abnormal mucosal functions. This questions the common assumption that increased mucosal inflammation and permeability initiate functional disorders in obesity.
- 3 January 2012
- Published by Wiley in The Journal of Physiology
- Vol. 590 (3) , 533-544
Diet‐induced obesity has neuroprotective effects in murine gastric enteric nervous system: involvement of leptin and glial cell line‐derived neurotrophic factor
Non‐technical summary The enteric nervous system (ENS) is an autonomous nervous system integrated along the gut that controls major gastrointestinal (GI) functions such as motility. Increasing data have demonstrated that nutritional factors can modulate the ENS phenotype and consequently impact upon GI functions. Western diet is central in the development of obesity but surprisingly no study has characterized its impact upon ENS phenotype and functions. We show that Western diet‐induced obesity (DIO) prevented age‐associated loss in a specific population of enteric neurons leading to an acceleration of gastric emptying. In addition, we showed that neuroprotective effects of DIO likely involved leptin and glial cell line‐derived neurotrophic factor (GDNF). This is the first study demonstrating an impact of DIO upon the ENS. These DIO‐induced neuroplastic changes in the ENS could be involved in the physiopathology of obesity.
- 3 January 2012
- Published by Wiley in The Journal of Physiology
- Vol. 590 (3) , 533-544
Diet‐induced obesity has neuroprotective effects in murine gastric enteric nervous system: involvement of leptin and glial cell line‐derived neurotrophic factor
Non‐technical summary The enteric nervous system (ENS) is an autonomous nervous system integrated along the gut that controls major gastrointestinal (GI) functions such as motility. Increasing data have demonstrated that nutritional factors can modulate the ENS phenotype and consequently impact upon GI functions. Western diet is central in the development of obesity but surprisingly no study has characterized its impact upon ENS phenotype and functions. We show that Western diet‐induced obesity (DIO) prevented age‐associated loss in a specific population of enteric neurons leading to an acceleration of gastric emptying. In addition, we showed that neuroprotective effects of DIO likely involved leptin and glial cell line‐derived neurotrophic factor (GDNF). This is the first study demonstrating an impact of DIO upon the ENS. These DIO‐induced neuroplastic changes in the ENS could be involved in the physiopathology of obesity.
- Open Access
- 3 February 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2) , e9043
Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
Suboptimal activation of T lymphocytes by melanoma cells is often due to the defective expression of class I major histocompatibility antigens (MHC-I) and costimulatory molecules. We have previously shown that geranylgeranyl transferase inhibition (done with GGTI-298) stimulates anti-melanoma immune response through MHC-I and costimulatory molecule expression in the B16F10 murine model [1]. In this study, it is shown that vaccination with mIFN-gand GGTI-298 pretreated B16F10 cells induces a protection against untreated tumor growth and pulmonary metastases implantation. Furthermore, using a human melanoma model (LB1319-MEL), we demonstrated that in vitro treatment with hIFN-γ and GGTI-298 led to the up regulation of MHC-I and a costimulatory molecule CD86 and down regulation of an inhibitory molecule PD-1L. Co-culture experiments with peripheral blood mononuclear cells (PBMC) revealed that modifications induced by hIFN-γ and GGTI-298 on the selected melanoma cells, enables the stimulation of lymphocytes from HLA compatible healthy donors. Indeed, as compared with untreated melanoma cells, pretreatment with hIFN-γ and GGTI-298 together rendered the melanoma cells more efficient at inducing the: i) activation of CD8 T lymphocytes (CD8+/CD69+); ii) proliferation of tumor-specific CD8 T cells (MelanA-MART1/TCR+); iii) secretion of hIFN-γ; and iv) anti-melanoma specific cytotoxic cells. These data indicate that pharmacological treatment of melanoma cell lines with IFN-γ and GGTI-298 stimulates their immunogenicity and could be a novel approach to produce tumor cells suitable for vaccination and for stimulation of anti-melanoma effector cells.
- 3 February 2010
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2) , e9043
Open AccessMelanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
Suboptimal activation of T lymphocytes by melanoma cells is often due to the defective expression of class I major histocompatibility antigens (MHC-I) and costimulatory molecules. We have previously shown that geranylgeranyl transferase inhibition (done with GGTI-298) stimulates anti-melanoma immune response through MHC-I and costimulatory molecule expression in the B16F10 murine model [1]. In this study, it is shown that vaccination with mIFN-gand GGTI-298 pretreated B16F10 cells induces a protection against untreated tumor growth and pulmonary metastases implantation. Furthermore, using a human melanoma model (LB1319-MEL), we demonstrated that in vitro treatment with hIFN-γ and GGTI-298 led to the up regulation of MHC-I and a costimulatory molecule CD86 and down regulation of an inhibitory molecule PD-1L. Co-culture experiments with peripheral blood mononuclear cells (PBMC) revealed that modifications induced by hIFN-γ and GGTI-298 on the selected melanoma cells, enables the stimulation of lymphocytes from HLA compatible healthy donors. Indeed, as compared with untreated melanoma cells, pretreatment with hIFN-γ and GGTI-298 together rendered the melanoma cells more efficient at inducing the: i) activation of CD8 T lymphocytes (CD8+/CD69+); ii) proliferation of tumor-specific CD8 T cells (MelanA-MART1/TCR+); iii) secretion of hIFN-γ; and iv) anti-melanoma specific cytotoxic cells. These data indicate that pharmacological treatment of melanoma cell lines with IFN-γ and GGTI-298 stimulates their immunogenicity and could be a novel approach to produce tumor cells suitable for vaccination and for stimulation of anti-melanoma effector cells.
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5)
S2087 Altered Gastrointestinal Motility During Western Diet-Induced Obesity in Mice
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5)
S2087 Altered Gastrointestinal Motility During Western Diet-Induced Obesity in Mice
- 8 May 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 382 (3) , 577-582
Neuroplasticity and neuroprotection in enteric neurons: Role of epithelial cells
- 8 May 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 382 (3) , 577-582
Neuroplasticity and neuroprotection in enteric neurons: Role of epithelial cells
- 1 December 2007
- Published by Elsevier in Gastroenterology
- Vol. 133 (6) , 1960-1970
Inducible Mouse Model of Chronic Intestinal Pseudo-Obstruction by Smooth Muscle-Specific Inactivation of the SRF Gene
- 1 December 2007
- Published by Elsevier in Gastroenterology
- Vol. 133 (6) , 1960-1970
Inducible Mouse Model of Chronic Intestinal Pseudo-Obstruction by Smooth Muscle-Specific Inactivation of the SRF Gene
- 1 July 2007
- Published by Wolters Kluwer Health in Shock
- Vol. 28 (1) , 118-124
MUCOSAL MAST CELL PROTEASES ARE INVOLVED IN COLONIC PERMEABILITY ALTERATIONS AND SUBSEQUENT BACTERIAL TRANSLOCATION IN ENDOTOXEMIC RATS
LPS-induced endotoxemia is associated with gut immune stimulation, mucosal inflammation, colonic paracellular permeability (CPP) alteration, and it promotes bacterial translocation (BT). Gut permeability increase linked to LPS promotes mucosal barrier dysfunction resulting to BT. However, the mechanisms involved in these alterations remain unknown. We aimed to evaluate the role of colonic mucosal mast cells and luminal serine protease activity (PA) in the alterations of CPP and BT induced by LPS. Rats receiving doxantrazole, a mast cell stabilizer, combined or not with LPS from Escherichia coli and CPP as well as BT were evaluated after each treatment. Mucosal mast cell activation was assessed by histological methods and by rat mast cell protease 2 level measurement in colonic content. Colonic luminal PA and mucosal inflammation (myeloperoxidase activity) were biochemically determined. In addition, the ability of luminal contents to act on CPP was evaluated in vitro in Ussing chambers. Peripheral administration of LPS promoted mast cell degranulation and increased CPP, BT, mucosal myeloperoxidase activity as well as rat mast cell protease 2 levels, and PA in colonic content. LPS-induced CPP increase and BT were prevented by doxantrazole. In vitro, exposure of the apical side of colonic tissues with supernatants from colonic contents of LPS-treated rats increased CPP. This effect was blocked by the serine protease inhibitor soybean trypsin inhibitor. Our data bring evidence of a key role of mucosal mast cells in LPS-induced increase of CPP and BT through the release of serine proteases into the colonic lumen.
- 1 July 2007
- Published by Wolters Kluwer Health in Shock
- Vol. 28 (1) , 118-124
MUCOSAL MAST CELL PROTEASES ARE INVOLVED IN COLONIC PERMEABILITY ALTERATIONS AND SUBSEQUENT BACTERIAL TRANSLOCATION IN ENDOTOXEMIC RATS
LPS-induced endotoxemia is associated with gut immune stimulation, mucosal inflammation, colonic paracellular permeability (CPP) alteration, and it promotes bacterial translocation (BT). Gut permeability increase linked to LPS promotes mucosal barrier dysfunction resulting to BT. However, the mechanisms involved in these alterations remain unknown. We aimed to evaluate the role of colonic mucosal mast cells and luminal serine protease activity (PA) in the alterations of CPP and BT induced by LPS. Rats receiving doxantrazole, a mast cell stabilizer, combined or not with LPS from Escherichia coli and CPP as well as BT were evaluated after each treatment. Mucosal mast cell activation was assessed by histological methods and by rat mast cell protease 2 level measurement in colonic content. Colonic luminal PA and mucosal inflammation (myeloperoxidase activity) were biochemically determined. In addition, the ability of luminal contents to act on CPP was evaluated in vitro in Ussing chambers. Peripheral administration of LPS promoted mast cell degranulation and increased CPP, BT, mucosal myeloperoxidase activity as well as rat mast cell protease 2 levels, and PA in colonic content. LPS-induced CPP increase and BT were prevented by doxantrazole. In vitro, exposure of the apical side of colonic tissues with supernatants from colonic contents of LPS-treated rats increased CPP. This effect was blocked by the serine protease inhibitor soybean trypsin inhibitor. Our data bring evidence of a key role of mucosal mast cells in LPS-induced increase of CPP and BT through the release of serine proteases into the colonic lumen.
- Open Access
- 21 March 2007
- Published by Wiley in The Journal of Physiology
- Vol. 580 (1) , 347-356
Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin‐releasing factor and nerve growth factor interplay
Neonatal maternal deprivation (NMD) increases gut paracellular permeability (GPP) through mast cells and nerve growth factor (NGF), and modifies corticotrophin‐releasing factor (CRF) and corticosterone levels. CRF, corticosterone and mast cells are involved in stress‐induced mucosal barrier impairment. Consequently, this study aimed to specify whether corticosteronaemia and colonic expression of both preproCRF and CRF are modified by NMD, and to determine if altered expression may participate in the elevated GPP in connection with NGF and mast cells. Male Wistar rat pups were either separated from postnatal days 2–14, or left undisturbed with their dam. At 12 weeks of age, adult rats were treated with mifepristone (an antagonist of corticoid receptors), α‐helical CRF(9‐41) (a non‐specific CRF receptor antagonist), or SSR‐125543 (CRF‐R1 receptor antagonist). We also determined corticosteronaemia and both colonic preproCRF and CRF expression. Then, control rats were treated by CRF, doxantrazole (mast cell stabilizer), BRX‐537A (a mast cell activator) and anti‐NGF antibody. NMD did not modify colonic CRF level but increased colonic preproCRF expression and corticosteronaemia. Peripheral CRF, via CRF‐R1 receptor, but not corticosterone, was involved in the elevated GPP observed in these rats, through a mast‐cell‐mediated mechanism, since the increase of GPP induced by exogenous CRF was abolished by doxantrazole. Anti‐NGF antibody treatment also reduced the elevated GPP induced by CRF or BRX‐537A. CRF acts through CRF‐R1 receptors to stimulate NGF release from mast cells, which participates in the elevated GPP observed in NMD adult rats. This suggests that early traumatic experience induced neuro‐endocrine dysfunction, involved in alterations of gut mucosal barrier.
- 21 March 2007
- Published by Wiley in The Journal of Physiology
- Vol. 580 (1) , 347-356
Open AccessPathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin‐releasing factor and nerve growth factor interplay
Neonatal maternal deprivation (NMD) increases gut paracellular permeability (GPP) through mast cells and nerve growth factor (NGF), and modifies corticotrophin‐releasing factor (CRF) and corticosterone levels. CRF, corticosterone and mast cells are involved in stress‐induced mucosal barrier impairment. Consequently, this study aimed to specify whether corticosteronaemia and colonic expression of both preproCRF and CRF are modified by NMD, and to determine if altered expression may participate in the elevated GPP in connection with NGF and mast cells. Male Wistar rat pups were either separated from postnatal days 2–14, or left undisturbed with their dam. At 12 weeks of age, adult rats were treated with mifepristone (an antagonist of corticoid receptors), α‐helical CRF(9‐41) (a non‐specific CRF receptor antagonist), or SSR‐125543 (CRF‐R1 receptor antagonist). We also determined corticosteronaemia and both colonic preproCRF and CRF expression. Then, control rats were treated by CRF, doxantrazole (mast cell stabilizer), BRX‐537A (a mast cell activator) and anti‐NGF antibody. NMD did not modify colonic CRF level but increased colonic preproCRF expression and corticosteronaemia. Peripheral CRF, via CRF‐R1 receptor, but not corticosterone, was involved in the elevated GPP observed in these rats, through a mast‐cell‐mediated mechanism, since the increase of GPP induced by exogenous CRF was abolished by doxantrazole. Anti‐NGF antibody treatment also reduced the elevated GPP induced by CRF or BRX‐537A. CRF acts through CRF‐R1 receptors to stimulate NGF release from mast cells, which participates in the elevated GPP observed in NMD adult rats. This suggests that early traumatic experience induced neuro‐endocrine dysfunction, involved in alterations of gut mucosal barrier.